Get the latest news and updates on FINTECH.TV

Eye Care Is Egypt’s Next Healthcare Consolidation Target

Egypt’s private hospital market is consolidating, and specialist care is now in play. On Capital Markets: Wall Street to MENA, host Bassel Sabri notes that Alameda, backed by $190 million in private equity, is reportedly negotiating control of the iCare eye hospital chain, and asks who will own Egypt’s next generation of specialist hospitals.

Dr. Ihab Othman, founder and chairman of Eye World Hospital, says an independent operator with multiple buildings and growing capacity can negotiate from a position of strength, because trusted individual doctors still matter in the eye business. He believes eye care attracts consolidators because it depends on high volume and low bed intensity, with short stays, repeatable procedures, a cash-based elective mix and premium services such as advanced lenses. He also points to Egypt’s location, within four hours’ flight of 500 million people, and says one of his targets is a million patients a year over the next three years.

On why exits are hard, Dr. Ihab Othman says currency swings have eroded dollar returns, including the 2016 float and the 2022 to 2024 devaluation, and that health care has few natural buyers. He also describes what he calls the founder-doctor holdup, arguing that owning 51% on paper does not mean owning the patient relationships, and that buyers who leave doctors out of the deal can lose as much as 30% of the business immediately.

Advertisement

Latest articles

Related articles